Gubra A/S (GUBRA) - Total Assets
Based on the latest financial reports, Gubra A/S (GUBRA) holds total assets worth Dkr1.32 Billion DKK (≈ $206.50 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check GUBRA cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Gubra A/S - Total Assets Trend (2019–2025)
This chart illustrates how Gubra A/S's total assets have evolved over time, based on quarterly financial data. Check Gubra A/S cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Gubra A/S - Asset Composition Analysis
Current Asset Composition (December 2025)
Gubra A/S's total assets of Dkr1.32 Billion consist of 87.9% current assets and 12.1% non-current assets.
| Asset Category | Amount (DKK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 2.4% |
| Accounts Receivable | Dkr72.59 Million | 5.5% |
| Inventory | Dkr0.00 | 0.0% |
| Property, Plant & Equipment | Dkr0.00 | 0.0% |
| Intangible Assets | Dkr13.22 Million | 1.0% |
| Goodwill | Dkr0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how Gubra A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Gubra A/S stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Gubra A/S's current assets represent 87.9% of total assets in 2025, an increase from 52.7% in 2019.
- Cash Position: Cash and equivalents constituted 2.4% of total assets in 2025, down from 23.9% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 5.5% of total assets.
Gubra A/S Competitors by Total Assets
Key competitors of Gubra A/S based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX
|
USA | $8.68 Billion |
|
Royalty Pharma Plc
NASDAQ:RPRX
|
USA | $19.82 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
SillaJen Inc
KQ:215600
|
Korea | ₩124.38 Billion |
|
Verona Pharma plc
F:I9SA
|
Germany | €572.87 Million |
|
Abivax SA
PA:ABVX
|
France | €584.34 Million |
|
ABL Bio Inc
KQ:298380
|
Korea | ₩298.13 Billion |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278
|
China | CN¥3.21 Billion |
Gubra A/S - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 13.63 | 6.06 | 1.87 |
| Quick Ratio | 13.63 | 6.06 | 1.87 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Dkr1.08 Billion | Dkr401.70 Million | Dkr54.41 Million |
Gubra A/S - Advanced Valuation Insights
This section examines the relationship between Gubra A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.61 |
| Latest Market Cap to Assets Ratio | 0.64 |
| Asset Growth Rate (YoY) | 115.5% |
| Total Assets | Dkr1.32 Billion |
| Market Capitalization | $848.91 Million USD |
Valuation Analysis
Below Book Valuation: The market values Gubra A/S's assets below their book value (0.64x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Gubra A/S's assets grew by 115.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Gubra A/S (2019–2025)
The table below shows the annual total assets of Gubra A/S from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Dkr1.32 Billion ≈ $206.50 Million |
+115.49% |
| 2024-12-31 | Dkr612.48 Million ≈ $95.83 Million |
-2.05% |
| 2023-12-31 | Dkr625.28 Million ≈ $97.83 Million |
+137.84% |
| 2022-12-31 | Dkr262.90 Million ≈ $41.13 Million |
-12.98% |
| 2021-12-31 | Dkr302.12 Million ≈ $47.27 Million |
+54.80% |
| 2020-12-31 | Dkr195.17 Million ≈ $30.54 Million |
+14.75% |
| 2019-12-31 | Dkr170.08 Million ≈ $26.61 Million |
-- |
About Gubra A/S
Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green. The company offers preclinical contract research and development services within metabolic and fibrotic diseases for th… Read more